Clinical Outcomes Comparison in Administration of Secretome vs Hyaluronic Acid in Patients with Knee Osteoarthritis Kellgren-Lawrence Grade I-III
Abstract
Background: The prevalence of OA in Indonesia is predicted to reach more than 20% of the population aged over 60 years in 2050, with a high risk of disability. So far, early treatment of osteoarthritis in the form of administering hyaluronic acid has not been completely satisfactory and tends to be progressive until ending in more invasive operative therapy. This study aimed to compare the clinical outcomes between secretome injection and hyaluronic acid in patients with Kellgren-Lawrence grade I-III knee osteoarthritis.
Subjects and Method: This was a single-blind experimental study. This study was conducted in the orthopedic polyclinic at General Hospital Prof. Dr. I.G.N.G. Ngoerah Bali. A total sample of 36 knee osteoarthritis patients was selected using permuted block sampling with randomization. The sample was divided into two groups, (1) secretome (intervention group) and (2) hyaluronic acid (control group). The independent variables were secretome injection and hyaluronic acid injection. The dependent variable was pain. Pain was measured using Western Ontario and McMaster University (WOMAC), Knee Osteoarthritis Outcome Score (KOOS), Visual Analog Score (VAS), and Patient-Reported Outcome Measure (PROM).
Results: Based on gender, there are more women than men and the right foot is more affected at 58.3%. Functional score parameters in each secretome and hyluronic acid group were compared between the 3rd and 6th months of follow-up. Pain in the hyaluronic acid group was lower than in the secretome group.
Conclusion: Hyaluronic acid has better effect in pain reduction than secretome. Further studies could explore the underlying mechanisms and potential long-term effects to better understand these differences in pain outcomes.
Keywords:
hyaluronic acid, knee, osteoarthritis, secretomeReferences
Abate M, Vanni D, Pantalone A, Salini V (2017). Hyaluronic acid in knee osteoarthritis: preliminary results using a four months administration schedule. Int J Rheumatic Dis. 20(2): 199–202. https://doi.org/10.1111/1756-185x.12572.
Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E (2016) Product Diffe-rences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee. Am J Sports Med. 44(8): 2158–2165. https://doi.org/10.1177/0363546515-609599.
Amo C del, Perez-Valle A, Atilano L, Andia I (2022). Unraveling the signaling secretome of platelet-rich plasma: Towards a better understanding of its therapeutic potential in knee osteo-arthritis. J Clin Med. 11(3): 473. https://doi.org/10.3390/jcm11030473.
Amodeo G, Niada S, Moschetti G, Franchi S, Savadori P, Brini AT, Sacerdote P (2021). Secretome of human adipose-derived mesenchymal stem cell relieves pain and neuroinflammation independently of the route of admi-nistration in experimental osteoarth-ritis. Brain Behav Immun. 94: 29-40. https://doi.org/10.1016/j.bbi.2021.03.011.
Anitua E, Sánchez M, Orive G, Andia I (2007). The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 28(31): 4551-60. https:-//doi.org/10.1016/j.biomaterials.2007.06.037.
Antony J, McGuinness K, O’Connor NE, Moran K (2016). Quantifying radio-graphic knee osteoarthritis severity using deep convolutional neural networks. In: 2016 23rd International Conference on Pattern Recognition (ICPR), December 2016: 1195–1200.
Ayhan E, Kesmezacar H, Akgun I (2014) Intraarticular injections (corticoste-roid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthoped. 5(3): 351-361. https://doi.org/10.5312/wjo.v5.i3.351
Bousnaki M, Bakopoulou A, Kritis A, Koidis P (2020). The efficacy of stem cells secretome application in osteo-arthritis: A systematic review of in vivo studies. Stem Cell Rev Rep. 16(6): 1222-1241. https://doi.org/10.1007/s12015-020-09980-x.
Charlesworth J, Fitzpatrick J, Perera NKP, Orchard J (2019). Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee. BMC Musculoskelet Disord. 20(1): 151. https://doi.org/10.1186/-s12891-019-2525-0.
Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H (2020a). Global, regional preva-lence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 29–30. https://doi.org/10.1016/j.eclinm.2020.100587.
D’arrigo D, Roffi A, Cucchiarini M, Moretti M, Candrian C, Filardo G (2019). Se-cretome and Extracellular Vesicles as New Biological Therapies for Knee Osteoarthritis: A Systematic Review. J Clin Med. 8(11): 1867. https://doi.org/10.3390/jcm8111867.
Delgado DA, Lambert BS, Boutris N, et al. (2018). Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev. 2(3): e088. https://doi.org/10.5435/jaaosglobal-d-17-00088.
Gigis I, Fotiadis E, Nenopoulos A, et al. (2016). Comparison of two different molecular weight intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis. Hippokratia. 20(1): 26–31. https://pmc.-ncbi.nlm.nih.gov/articles/PMC5074393/.
Gupta A (2022). Autologous adipose tissue vs. platelet-rich plasma for treatment of knee osteoarthritis. Biomedicines. 10(10):2527. https://doi.org/10.3390-/biomedicines10102527.
Gupta RC, Lall R, Srivastava A, Sinha A (2019). Hyaluronic acid: Molecular mechanisms and therapeutic trajec-tory. Front Vet Sci. 6:192. https://-doi.org/10.3389/fvets.2019.00192.
Hafez AR, Alenazi AM, Kachanathu SJ, Alroumi AM, Mohamed ES (2014). Knee osteoarthritis: A review of literature. Phys Med Rehabil Int. 1(5): 8. https://austinpublishinggroup.com/physical-medicine/fulltext/pmr-v1-id1021.php.
He Y, Li Z, Alexander PG, Ocasio-Nieves BD, Yocum L, Lin H, Tuan RS (2020). Pathogenesis of osteoarthritis: Risk factors, regulatory pathways in chondrocytes, and experimental models. Biology. 9(8): 194. https://doi.org/-10.3390/biology9080194.
Hochberg MC, Altman RD, April KT, Ben-khalti M, Guyatt G, McGowan J, Towheed T, et al. (2012). American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care & Research 64(4): 465–474. https://doi.org/10.1002/acr.21596.
Hunter DJ and Bierma-Zeinstra S (2019a). Osteoarthritis. Lancet. 393(10182): 1745-1759. https://doi.org/10.1016/-s0140-6736(19)30417-9.
Iijima H, Isho T, Kuroki H, et al. (2018). Effectiveness of mesenchymal stem cells for treating patients with knee osteoarthritis: a meta-analysis toward the establishment of effective regenerative rehabilitation. NPJ Regen Med. 3(1): 15. https://doi.org/10.1038/s41536-018-0041-8.
Jang S, Lee K, Ju JH (2021). Recent updates of diagnosis, pathophysio-logy, and treatment on osteoarthritis of the knee. Int J Mol Sci. 22(5):2619. https://doi.org/10.3390/ijms22052619.
Kim YS, Suh DS, Tak DH, Chung PK, Kwon YB, Kim TY, Koh YG (2020). Compa-rative matched-pair cohort analysis of the short-term clinical outcomes of mesenchymal stem cells versus hyaluronic acid treatments through intra-articular injections for knee osteoarthritis. J Exp Orthop. 7(1):90. https://doi.org/10.1186/s40634-020-00310-1.
Kohn MD, Sassoon AA, Fernando ND (2016). Classifications in Brief: Kellgren-Lawrence Classification of Osteoarthritis. Clin Orthop Relat Res. 474(8): 1886–1893. https://doi.org/10.1007/s11999-016-4732-4.
Koiri SP, Yang Y, Kui H (2018). Hyaluronic acid in the treatment of knee osteo-arthritis: Review. Yangtze Medicine. 02(02): 62–72. https://doi.org/10.42-36/ym.2018.22007.
Lopa S, Colombini A, Moretti M, de Giro-lamo L (2019). Injective mesenchymal stem cell-based treatments for knee osteoarthritis: from mechanisms of action to current clinical evidences. Knee Surg Sports Traumatol Arthrosc. 27(6): 2003-2020. https://doi.org/-10.1007/s00167-018-5118-9.
Maheu E, Zaim M, Appelboom T, Jeka S, Trc T, Berenbaum F, Maasalu K, et al. (2011). Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, pros-pective, randomized, controlled trial. Clin Exp Rheumatol. 29(3): 527–35. https://pubmed.ncbi.-nlm.nih.gov/21722501/.
Migliore A (2015). Effectiveness and utility of hyaluronic acid in osteoarthritis. Clin Cases Miner Bone Metab. 12(1): 31-3. https://doi.org/10.11138/ccmb-m/2015.12.1.031.
Miller LE, Bhattacharyya S, Parrish WR, Fredericson M, Bisson B, Altman RD (2021). Safety of intra-articular hyaluronic acid for knee osteo-arthritis: Systematic review and meta-analysis of randomized trials involving more than 8,000 patients. Cartilage. 13(1): 351S-363S. https://doi.org/10.1177/-1947603519888783.
Műzes G, Sipos F (2022). Mesenchymal stem cell-derived secretome: A potential therapeutic option for auto-immune and immune-mediated inflammatory diseases. Cells. 11(15): 2300. https://doi.org/10.3390/cells11152300.
Nabavizadeh SS, Talaei-Khozani T, Zarei M, Zare S, Hosseinabadi OK, Tanideh N, Daneshi S (2021). Attenuation of osteoarthritis progression via a com-bination of intra-articular injection of synovial membrane-derived MSCs (SMMSCs), platelet rich plasma (PRP) and conditioned medium (Secretome). J Orthop Surg Res. https://doi.org/10.1186/s13018-021-02851-2.
Partan RU, Putra KM, Kusuma NF, Darma S, Reagan M, Muthia P, Radiandina AS, et al. (2023). Umbilical cord mesenchymal stem cell secretome improves clinical outcomes and changes biomarkers in knee osteo-arthritis. J Clin Med. 12(22):7138. https://doi.org/10.3390/jcm12227138.
Rachmat N, Janmo Minulyo A, Zubaidi A (2021). An overview of the quality of life of knee osteoarthritis patients at the surakarta orthopedic hospital. Jurnal Keterapian Fisik. 6(1): 38–48. https://doi.org/10.37341/jkf.v0i0.271
Ramkumar PN, Harris JD, Noble PC (2015) Patient-reported outcome measures after total knee arthroplasty. Bone Joint Res. 4(7): 120–127. https://doi.-org/10.1302/2046-3758.47.2000380.
Roos EM, Toksvig-Larsen S (2003). Health and quality of life outcomes knee injury and osteoarthritis outcome score (KOOS)-validation and compa-rison to the WOMAC in total knee replacement. Health Qual Life Out-comes. 1: 17. https://doi.org/10.1186-/1477-7525-1-17.
Saccomano SJ (2018). Osteoarthritis treat-ment. The Nurse Practitioner 43(9): 49–55. https://doi.org/10.1097/01.n-pr.0000544281.05010.86.
Salaffi F, Carotti M, Stancati A, Grassi W (2003). Radiographic assessment of osteoarthritis: Analysis of disease progression. Aging Clin Exp Res. 15(5): 391–404. https://doi.org/10.1007/bf-03327360.
Samma L, Rasjad C, Prihantono, Seweng A, Haryasena, Latief J, Bausat A, et al. (2021). Correlation between body mass index (BMI), visual analogue scale (VAS) score and knee osteo-arthritis grading. Medicina Clínica Práctica. 4(1): 100228. https://doi.-org/10.1016/j.mcpsp.2021.100228.
Santilli V (2016). Hyaluronic acid in the management of osteoarthritis: injec-tion therapies innovations. Clin Cases Miner Bone Metab. 13(2):131–134. https://doi.org/10.11138/ccmbm/2016.13.2.131.
Schelbergen RF, van Dalen S, ter Huurne M, Roth J, Vogl T, Noël D, Jorgensen C, et al. (2014). Treatment efficacy of adipose-derived stem cells in experi-mental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels. Osteo-arthritis Cartilage 22(8): 1158–1166. https:-//doi.org/10.1016/j.joca.2014.05.022.
Sharma L (2021) Osteoarthritis of the Knee. N England J Med. 384(1): 51–59. https://doi.org/10.1056/nejmcp1903768.
Shimizu H, Shimoura K, Iijima H, Suzuki Y, Aoyama T (2022). Functional manifestations of early knee osteoarthritis: a systematic review and meta-analysis. Clinical Rheumatology 41(9): 2625–2634. https://doi.org/10.1007/s10067-022-06150-x.
Shoukrie SI, Venugopal S, Dhanoa RK, et al. (2022). Safety and efficacy of injecting mesenchymal stem cells into a human knee joint to treat osteo-arthritis: A systematic review. Cureus. 14(5): e24823. https://doi.org/10.77-59/cureus.24823.
Sopiyudin Dahlan (2009). Besar sampel dan cara pengambilan sampel dalam penelitian kedokteran dan kesehatan. Jakarta: Salemba Medika.
Tamer TM (2013). Hyaluronan and syno-vial joint: function, distribution and healing. Interdisciplinary Toxicology 6(3): 111–125. https://pubmed.ncbi.-nlm.nih.gov/24678248/.
Teixeira FG, Carvalho MM, Sousa N, Salgado AJ (2013). Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?. Cell Mol Life Sci. 70(20): 3871–3882. https://doi.org/10.1007/s00018-013-1290-8.
Wang YC, Lee CL, Chen YJ, Tien YC, Lin SY, Chen CH, Chou PPH, Huang HT (2022) Comparing the efficacy of intra-articular single platelet-rich plasma (PRP) versus novel cross-linked hyaluronic acid for early-stage knee osteoarthritis: A prospective, double-blind, randomized controlled trial. Medicina (Kaunas). 58(8): 1028. https://doi.org/10.3390/medicina58081028.
Wasterlain AS, Braun HJ, Harris AHS, Kim HJ, Dragoo JL (2012). The systemic effects of platelet-rich plasma injection. Am J Sports Med. 41(1): 186-93. https://doi.org/10.1177/0363546512-466383.
Zhang H, Zhang K, Zhang X, Zhu Z, Yan S, Sun T, Guo A, et al. (2015) Compa-rison of two hyaluronic acid formula-tions for safety and efficacy (CHASE) study in knee osteoarthritis: a multi-center, randomized, double-blind, 26-week non-inferiority trial comparing Durolane to Artz. Arthritis Research & Therapy 17(1): 51. https://doi.org/10.1186/s13075-015-0557-x.
